{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:07:51Z","timestamp":1792112871737,"version":"4.4.0"},"reference-count":82,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2,1]]},"abstract":"<jats:p>Over the past 3 decades, the prevalence of childhood obesity has increased dramatically in North America, ushering in a variety of health problems, including type 2 diabetes mellitus (T2DM), which previously was not typically seen until much later in life. The rapid emergence of childhood T2DM poses challenges to many physicians who find themselves generally ill-equipped to treat adult diseases encountered in children. This clinical practice guideline was developed to provide evidence-based recommendations on managing 10- to 18-year-old patients in whom T2DM has been diagnosed. The American Academy of Pediatrics (AAP) convened a Subcommittee on Management of T2DM in Children and Adolescents with the support of the American Diabetes Association, the Pediatric Endocrine Society, the American Academy of Family Physicians, and the Academy of Nutrition and Dietetics (formerly the American Dietetic Association). These groups collaborated to develop an evidence report that served as a major source of information for these practice guideline recommendations. The guideline emphasizes the use of management modalities that have been shown to affect clinical outcomes in this pediatric population. Recommendations are made for situations in which either insulin or metformin is the preferred first-line treatment of children and adolescents with T2DM. The recommendations suggest integrating lifestyle modifications (ie, diet and exercise) in concert with medication rather than as an isolated initial treatment approach. Guidelines for frequency of monitoring hemoglobin A1c (HbA1c) and finger-stick blood glucose (BG) concentrations are presented. Decisions were made on the basis of a systematic grading of the quality of evidence and strength of recommendation. The clinical practice guideline underwent peer review before it was approved by the AAP. This clinical practice guideline is not intended to replace clinical judgment or establish a protocol for the care of all children with T2DM, and its recommendations may not provide the only appropriate approach to the management of children with T2DM. Providers should consult experts trained in the care of children and adolescents with T2DM when treatment goals are not met or when therapy with insulin is initiated. The AAP acknowledges that some primary care clinicians may not be confident of their ability to successfully treat T2DM in a child because of the child\u2019s age, coexisting conditions, and\/or other concerns. At any point at which a clinician feels he or she is not adequately trained or is uncertain about treatment, a referral to a pediatric medical subspecialist should be made. If a diagnosis of T2DM is made by a pediatric medical subspecialist, the primary care clinician should develop a comanagement strategy with the subspecialist to ensure that the child continues to receive appropriate care consistent with a medical home model in which the pediatrician partners with parents to ensure that all health needs are met.<\/jats:p>","DOI":"10.1542\/peds.2012-3494","type":"journal-article","created":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T02:29:24Z","timestamp":1359426564000},"page":"364-382","source":"Crossref","is-referenced-by-count":262,"title":["Management of Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) in Children and Adolescents"],"prefix":"10.1542","volume":"131","author":[{"given":"Kenneth C.","family":"Copeland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Silverstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly R.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg E.","family":"Prazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Raymer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard N.","family":"Shiffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley C.","family":"Springer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidhu V.","family":"Thaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meaghan","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Spann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan K.","family":"Flinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2013,2,1]]},"reference":[{"key":"2021120903240402400_B1","unstructured":"Centers for Disease Control and Prevention. Data and Statistics. Obesity rates among children in the United States. Available at: www.cdc.gov\/obesity\/childhood\/prevalence.html. Accessed August 13, 2012"},{"issue":"9","key":"2021120903240402400_B2","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3928\/0090-4481-20050901-09","article-title":"Type 2 diabetes in children: oxymoron or medical metamorphosis?","volume":"34","author":"Copeland","year":"2005","journal-title":"Pediatr Ann"},{"issue":"14","key":"2021120903240402400_B3","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1001\/jama.290.14.1884","article-title":"Lifetime risk for diabetes mellitus in the United States.","volume":"290","author":"Narayan","year":"2003","journal-title":"JAMA"},{"issue":"12","key":"2021120903240402400_B4","first-page":"952","article-title":"A global response to a global problem: the epidemic of overnutrition.","volume":"80","author":"Chopra","year":"2002","journal-title":"Bull World Health Organ"},{"issue":"4","key":"2021120903240402400_B5","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1542\/peds.2006-0690","article-title":"The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study.","volume":"118","author":"Liese","year":"2006","journal-title":"Pediatrics"},{"issue":"1","key":"2021120903240402400_B6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11892-001-0006-x","article-title":"Type 2 diabetes in children.","volume":"1","author":"Silverstein","year":"2001","journal-title":"Curr Diab Rep"},{"key":"2021120903240402400_B7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1399-5448.2007.00330.x","article-title":"Clinical presentation and treatment of type 2 diabetes in children.","volume":"8","author":"Pinhas-Hamiel","year":"2007","journal-title":"Pediatr Diabetes"},{"issue":"24","key":"2021120903240402400_B8","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1001\/jama.297.24.2716","article-title":"Incidence of diabetes in youth in the United States.","volume":"297","author":"Dabelea","year":"2007","journal-title":"JAMA"},{"key":"2021120903240402400_B9","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.2337\/dc09-S201","article-title":"The many faces of diabetes in American youth: type 1 and type 2 diabetes in five race and ethnic populations: the SEARCH for Diabetes in Youth Study.","volume":"32","author":"Mayer-Davis","year":"2009","journal-title":"Diabetes Care"},{"issue":"1","key":"2021120903240402400_B10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1210\/jc.2010-1642","article-title":"Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline.","volume":"96","author":"Copeland","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2021120903240402400_B11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pcd.2008.12.001","article-title":"Diabetes\u2014a global problem needing global solutions.","volume":"3","author":"Narayan","year":"2009","journal-title":"Prim Care Diabetes"},{"issue":"5","key":"2021120903240402400_B12","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"issue":"1","key":"2021120903240402400_B13","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2337\/diacare.28.1.186","article-title":"Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association.","volume":"28","author":"Silverstein","year":"2005","journal-title":"Diabetes Care"},{"issue":"1","key":"2021120903240402400_B14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1034\/j.1399-5448.2003.00027.x","article-title":"Barriers to the treatment of adolescent type 2 diabetes\u2014a survey of provider perceptions.","volume":"4","author":"Pinhas-Hamiel","year":"2003","journal-title":"Pediatr Diabetes"},{"issue":"5","key":"2021120903240402400_B15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/19325037.2009.10599106","article-title":"Community resources for promoting youth nutrition and physical activity.","volume":"40","author":"Moore","year":"2009","journal-title":"Am J Health Educ"},{"issue":"2","key":"2021120903240402400_B16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1399-5448.2007.00237.x","article-title":"Treatment Options for type 2 diabetes mellitus in Adolescents and Youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes mellitus.","volume":"8","author":"Zeitler","year":"2007","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"2021120903240402400_B17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2174\/1573399052952569","article-title":"The utility of oral diabetes medications in type 2 diabetes of the young.","volume":"1","author":"Kane","year":"2005","journal-title":"Curr Diabetes Rev"},{"key":"2021120903240402400_B18"},{"key":"2021120903240402400_B19"},{"key":"2021120903240402400_B20","first-page":"547","article-title":"The role of the family in managing therapy in minority children with type 2 diabetes mellitus.","volume":"15","author":"Bradshaw","year":"2002","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"10","key":"2021120903240402400_B21","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/archpedi.153.10.1063","article-title":"The type 2 family: a setting for development and treatment of adolescent type 2 diabetes mellitus.","volume":"153","author":"Pinhas-Hamiel","year":"1999","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"5","key":"2021120903240402400_B22","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2337\/dc05-2099","article-title":"Parent perceptions of caring for adolescents with type 2 diabetes.","volume":"29","author":"Mulvaney","year":"2006","journal-title":"Diabetes Care"},{"issue":"3","key":"2021120903240402400_B23","first-page":"CD001872","article-title":"Interventions for treating obesity in children.","author":"Summerbell","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2021120903240402400_B24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2337\/dc07-1214","article-title":"Accuracy of perceptions of overweight and relation to self-care behaviors among adolescents with type 2 diabetes and their parents.","volume":"31","author":"Skinner","year":"2008","journal-title":"Diabetes Care"},{"issue":"3","key":"2021120903240402400_B25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2337\/diacare.23.3.381","article-title":"Type 2 diabetes in children and adolescents.","volume":"23","author":"American Diabetes Association","year":"2000","journal-title":"Diabetes Care"},{"issue":"12","key":"2021120903240402400_B26","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1542\/pir.19-12-434","article-title":"Type 2 diabetes in adolescents, no longer rare.","volume":"19","author":"Pinhas-Hamiel","year":"1998","journal-title":"Pediatr Rev"},{"issue":"5","key":"2021120903240402400_B27","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1067\/mpd.2000.105141","article-title":"Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective.","volume":"136","author":"Fagot-Campagna","year":"2000","journal-title":"J Pediatr"},{"issue":"4","key":"2021120903240402400_B28","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2007-1484","article-title":"Self-management behaviors, racial disparities, and glycemic control among adolescents with type 2 diabetes.","volume":"121","author":"Rothman","year":"2008","journal-title":"Pediatrics"},{"issue":"1","key":"2021120903240402400_B29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1542\/peds.100.1.84","article-title":"Characteristics of youth-onset noninsulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus at diagnosis.","volume":"100","author":"Scott","year":"1997","journal-title":"Pediatrics"},{"issue":"10","key":"2021120903240402400_B30","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.2337\/diacare.26.10.2871","article-title":"Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes.","volume":"26","author":"Libman","year":"2003","journal-title":"Diabetes Care"},{"key":"2021120903240402400_B31","article-title":"Technical report: management of type 2 diabetes mellitus in children and adolescents.","author":"Springer","journal-title":"Pediatrics"},{"issue":"3","key":"2021120903240402400_B32","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1542\/peds.2004-1260","article-title":"Classifying recommendations for clinical practice guidelines.","volume":"114","author":"American Academy of Pediatrics Steering Committee on Quality Improvement and Management","year":"2004","journal-title":"Pediatrics"},{"key":"2021120903240402400_B33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1472-6947-5-23","article-title":"The GuideLine Implementability Appraisal (GLIA): development of an instrument to identify obstacles to guideline implementation.","volume":"5","author":"Shiffman","year":"2005","journal-title":"BMC Med Inform Decis Mak"},{"issue":"6","key":"2021120903240402400_B34","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.pcl.2005.07.009","article-title":"Type 2 diabetes mellitus in youth: the complete picture to date.","volume":"52","author":"Gungor","year":"2005","journal-title":"Pediatr Clin North Am"},{"issue":"3","key":"2021120903240402400_B35","first-page":"255","article-title":"The management of type 2 diabetes in children and adolescents.","volume":"56","author":"Daaboul","year":"2004","journal-title":"Minerva Pediatr"},{"issue":"9","key":"2021120903240402400_B36","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1515\/JPEM.2004.17.9.1185","article-title":"Glycemic control with metformin or insulin therapy in adolescents with type 2 diabetes mellitus.","volume":"17","author":"Kadmon","year":"2004","journal-title":"J Pediatr Endocrinol"},{"issue":"2","key":"2021120903240402400_B37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/000992289803700209","article-title":"Treatment of NIDDM in youth.","volume":"37","author":"Owada","year":"1998","journal-title":"Clin Pediatr (Phila)"},{"key":"2021120903240402400_B38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.yapd.2005.03.008","article-title":"Advances in epidemiology and treatment of type 2 diabetes in children.","volume":"52","author":"Pinhas-Hamiel","year":"2005","journal-title":"Adv Pediatr"},{"key":"2021120903240402400_B39","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00019616-200010060-00005","article-title":"Type 2 diabetes mellitus in children and adolescence: a primer.","volume":"10","author":"Jones","year":"2000","journal-title":"Endocrinologist"},{"key":"2021120903240402400_B40"},{"key":"2021120903240402400_B41","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1515\/JPEM.2002.15.S2.737","article-title":"Type 2 diabetes mellitus in children and youth: a new epidemic.","volume":"15","author":"Kaufman","year":"2002","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"6","key":"2021120903240402400_B42","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0002-9343(97)00254-4","article-title":"Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial.","volume":"103","author":"Garber","year":"1997","journal-title":"Am J Med"},{"issue":"4","key":"2021120903240402400_B43","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0889-8529(05)70098-0","article-title":"Type 2 diabetes mellitus in minority children and adolescents: an emerging problem.","volume":"28","author":"Dabelea","year":"1999","journal-title":"Endocrinol Metabo Clin North Am"},{"issue":"2","key":"2021120903240402400_B44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1515\/JPEM.2005.18.2.111","article-title":"The management of type 2 diabetes mellitus in children and adolescents.","volume":"18","author":"Miller","year":"2005","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"2021120903240402400_B45","first-page":"107","article-title":"Type 2 diabetes in children and adolescents in a 2-year follow-up: insufficient adherence to diabetes centers.","volume":"69","author":"Reinehr","year":"2008","journal-title":"Horm Res"},{"key":"2021120903240402400_B46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1399-5448.2009.00584.x","article-title":"Type 2 diabetes in children and adolescents.","volume":"10","author":"Rosenbloom","year":"2009","journal-title":"Pediatr Diabetes"},{"key":"2021120903240402400_B47","first-page":"541","article-title":"Treatment of type 2 diabetes mellitus in children and adolescents.","volume":"15","author":"Zuhri-Yafi","year":"2002","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"6","key":"2021120903240402400_B48","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1515\/JPEM.2004.17.6.871","article-title":"Type 1 and type 2 diabetes mellitus in childhood in the United States: practice patterns by pediatric endocrinologists.","volume":"17","author":"Rapaport","year":"2004","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2021120903240402400_B49","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0065-3101(24)00079-3","article-title":"Non-insulin-dependent diabetes mellitus in children and adolescents.","volume":"43","author":"Glaser","year":"1996","journal-title":"Adv Pediatr"},{"issue":"4","key":"2021120903240402400_B50","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2165\/00024677-200605040-00001","article-title":"The treatment of type 2 diabetes mellitus in youth: which therapies?","volume":"5","author":"Miller","year":"2006","journal-title":"Treat Endocrinol"},{"key":"2021120903240402400_B51","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1515\/jpem-2000-s614","article-title":"Treatment of type 2 diabetes mellitus in children and adolescents.","volume":"13","author":"Silverstein","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"4","key":"2021120903240402400_B52","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/pch\/4.4.265","article-title":"Treatment of type 2 diabetes in youth: an argument for randomized controlled studies.","volume":"4","author":"Dean","year":"1999","journal-title":"Paediatr Child Health (Oxford)"},{"issue":"11","key":"2021120903240402400_B53","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1515\/JPEM.2004.17.11.1561","article-title":"Short-term insulin therapy in adolescents with type 2 diabetes mellitus.","volume":"17","author":"Sellers","year":"2004","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"24","key":"2021120903240402400_B54","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1109333","article-title":"A clinical trial to maintain glycemic control in youth with type 2 diabetes.","volume":"366","author":"Zeitler","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"2021120903240402400_B55","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1067\/mpd.2001.118887","article-title":"Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).","volume":"139","author":"White","year":"2001","journal-title":"J Pediatr"},{"issue":"14","key":"2021120903240402400_B56","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"issue":"5","key":"2021120903240402400_B57","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.2337\/diacare.26.5.1374","article-title":"Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study.","volume":"26","author":"Orchard","year":"2003","journal-title":"Diabetes Care"},{"issue":"11","key":"2021120903240402400_B58","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/diab.44.11.1249","article-title":"U.K. prospective diabetes study 16. Overview of 6 years\u2019 therapy of type II diabetes: a progressive disease.","volume":"44","author":"UK Prospective Diabetes Study Group","year":"1995","journal-title":"Diabetes"},{"key":"2021120903240402400_B59","first-page":"B21","article-title":"Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.","volume":"23","author":"Shichiri","year":"2000","journal-title":"Diabetes Care"},{"issue":"6","key":"2021120903240402400_B60","doi-asserted-by":"crossref","first-page":"602","DOI":"10.2337\/diacare.7.6.602","article-title":"National Diabetes Data Group: report of the expert committee on glucosylated hemoglobin.","volume":"7","author":"Baynes","year":"1984","journal-title":"Diabetes Care"},{"key":"2021120903240402400_B61","first-page":"A457","article-title":"Benefits of rosiglitazone in children with type 2 diabetes mellitus [abstract].","author":"Dabiri","year":"2005","journal-title":"Diabetes"},{"issue":"2","key":"2021120903240402400_B62","first-page":"95","article-title":"Type 2 diabetes mellitus in teens.","volume":"13","author":"Ponder","year":"2000","journal-title":"Diabetes Spectrum"},{"issue":"4","key":"2021120903240402400_B63","doi-asserted-by":"crossref","DOI":"10.1542\/peds.112.4.e328","article-title":"and the American Academy of Pediatrics Committee on Native American Child Health. Prevention and treatment of type 2 diabetes mellitus in children, with special emphasis on American Indian and Alaska Native children.","volume":"112","author":"Gahagan","year":"2003","journal-title":"Pediatrics"},{"issue":"2","key":"2021120903240402400_B64","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1067\/mpd.2001.116283","article-title":"Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes.","volume":"139","author":"Levine","year":"2001","journal-title":"J Pediatr"},{"issue":"5","key":"2021120903240402400_B65","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jpeds.2003.12.042","article-title":"Predictors of control of diabetes: monitoring may be the key.","volume":"144","author":"Haller","year":"2004","journal-title":"J Pediatr"},{"issue":"6","key":"2021120903240402400_B66","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2337\/diacare.26.6.1759","article-title":"Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).","volume":"26","author":"Murata","year":"2003","journal-title":"Diabetes Care"},{"key":"2021120903240402400_B67","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc11-S011","article-title":"Standards of medical care in diabetes\u20142011.","volume":"34","author":"American Diabetes Association","year":"2011","journal-title":"Diabetes Care"},{"issue":"12","key":"2021120903240402400_B68","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s001250050617","article-title":"Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up.","volume":"39","author":"Hanefeld","year":"1996","journal-title":"Diabetologia"},{"issue":"11","key":"2021120903240402400_B69","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.2337\/diacare.24.11.1870","article-title":"The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies.","volume":"24","author":"Franciosi","year":"2001","journal-title":"Diabetes Care"},{"key":"2021120903240402400_B70","unstructured":"American Dietetic Association. Recommendations summary: pediatric weight management (PWM) using protein sparing modified fast diets for pediatric weight loss. Available at: www.adaevidencelibrary.com\/template.cfm?template=guide_summary&key=416. Accessed August 13, 2012"},{"issue":"6","key":"2021120903240402400_B71","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"2021120903240402400_B72","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2337\/diacare.27.2.348","article-title":"Treatment of type 2 diabetes in childhood using a very-low-calorie diet.","volume":"27","author":"Willi","year":"2004","journal-title":"Diabetes Care"},{"issue":"2","key":"2021120903240402400_B73","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pedhc.2005.08.010","article-title":"Management of type 2 diabetes in youth (part 2).","volume":"20","author":"Berry","year":"2006","journal-title":"J Pediatr Health Care"},{"issue":"5","key":"2021120903240402400_B74","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11892-005-0098-9","article-title":"Nutrition therapy for overweight children and adolescents with type 2 diabetes.","volume":"5","author":"Loghmani","year":"2005","journal-title":"Curr Diab Rep"},{"issue":"4","key":"2021120903240402400_B75","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3132\/dvdr.2007.057","article-title":"Physical activity for the prevention and management of youth-onset type 2 diabetes mellitus: focus on cardiovascular complications.","volume":"4","author":"McGavock","year":"2007","journal-title":"Diab Vasc Dis Res"},{"key":"2021120903240402400_B76","unstructured":"Centers for Disease Control and Prevention. Physical activity for everyone: how much physical activity do you need? Atlanta, GA: Centers for Disease Control and Prevention; 2008. Available at: www.cdc.gov\/physicalactivity\/everyone\/guidelines\/children.html. Accessed August 13, 2012"},{"issue":"4","key":"2021120903240402400_B77","first-page":"292","article-title":"A weighty problem: diagnosis and treatment of type 2 diabetes in adolescents.","volume":"10","author":"Pinhas-Hamiel","year":"1997","journal-title":"Diabetes Spectrum"},{"issue":"6","key":"2021120903240402400_B78","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2337\/diacare.18.6.775","article-title":"Daily walking combined with diet therapy is a useful means for obese NIDDM patients not only to reduce body weight but also to improve insulin sensitivity.","volume":"18","author":"Yamanouchi","year":"1995","journal-title":"Diabetes Care"},{"key":"2021120903240402400_B79","unstructured":"National Heart, Lung, and Blood Institute, US Department of Health and Human Services, National Institutes of Health. Reduce screen time. Available at: www.nhlbi.nih.gov\/health\/public\/heart\/obesity\/wecan\/reduce-screen-time\/index.htm. Accessed August 13, 2012"},{"issue":"2","key":"2021120903240402400_B80","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1542\/peds.112.2.424","article-title":"Prevention of pediatric overweight and obesity.","volume":"112","author":"Krebs","year":"2003","journal-title":"Pediatrics"},{"issue":"2","key":"2021120903240402400_B81","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1542\/peds.107.2.423","article-title":"American Academy of Pediatrics: children, adolescents, and television.","volume":"107","author":"American Academy of Pediatrics Committee on Public Education","year":"2001","journal-title":"Pediatrics"},{"key":"2021120903240402400_B82","unstructured":"American Medical Association. Appendix. Expert Committee recommendations on the assessment, prevention, and treatment of child and adolescent overweight and obesity. Chicago, IL: American Medical Association; January 25, 2007. Available at: www.ama-assn.org\/ama1\/pub\/upload\/mm\/433\/ped_obesity_recs.pdf. Accessed August 13, 2012"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/131\/2\/364\/1089222\/peds_2012-3494.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/131\/2\/364\/1089222\/peds_2012-3494.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T07:32:21Z","timestamp":1714894341000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/131\/2\/364\/31847\/Management-of-Newly-Diagnosed-Type-2-Diabetes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,1]]},"references-count":82,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2,1]]},"published-print":{"date-parts":[[2013,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2012-3494","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,1]]}}}